470 related articles for article (PubMed ID: 17341866)
1. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.
Lin YK; Wong WR; Chang YC; Chang CJ; Tsay PK; Chang SC; Pang JH
Dermatology; 2007; 214(2):155-61. PubMed ID: 17341866
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.
Lin YK; Chang CJ; Chang YC; Wong WR; Chang SC; Pang JH
Arch Dermatol; 2008 Nov; 144(11):1457-64. PubMed ID: 19015420
[TBL] [Abstract][Full Text] [Related]
3. Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component.
Lin YK; Leu YL; Yang SH; Chen HW; Wang CT; Pang JH
J Dermatol Sci; 2009 Jun; 54(3):168-74. PubMed ID: 19303259
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of pediatric psoriasis with Indigo naturalis composite ointment.
Lin YK; Yen HR; Wong WR; Yang SH; Pang JH
Pediatr Dermatol; 2006; 23(5):507-10. PubMed ID: 17014654
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
7. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
8. Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes.
Hsieh WL; Lin YK; Tsai CN; Wang TM; Chen TY; Pang JH
J Dermatol Sci; 2012 Aug; 67(2):140-6. PubMed ID: 22721997
[TBL] [Abstract][Full Text] [Related]
9. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
Durakovic C; Ray S; Holick MF
Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890
[TBL] [Abstract][Full Text] [Related]
10. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
Vahlquist A; Törmä H; Carlsson B
Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560
[TBL] [Abstract][Full Text] [Related]
11. A Review of Indigo Naturalis as an Alternative Treatment for Nail Psoriasis.
McDermott L; Madan R; Rupani R; Siegel D
J Drugs Dermatol; 2016 Mar; 15(3):319-23. PubMed ID: 26954317
[TBL] [Abstract][Full Text] [Related]
12. Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study.
Lin YK; See LC; Chang YC; Huang YH; Chen JL; Tsou TC; Leu YL; Shen YM
Dermatology; 2011; 223(3):239-43. PubMed ID: 22056841
[TBL] [Abstract][Full Text] [Related]
13. Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial.
Lin YK; See LC; Huang YH; Chi CC; Hui RC
Br J Dermatol; 2018 Jan; 178(1):124-131. PubMed ID: 28815560
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
Carroll CL; Clarke J; Camacho F; Balkrishnan R; Feldman SR
Arch Dermatol; 2005 Jan; 141(1):43-6. PubMed ID: 15655140
[TBL] [Abstract][Full Text] [Related]
15. Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial.
Ormerod AD; Shah SA; Copeland P; Omar G; Winfield A
Br J Dermatol; 2005 Apr; 152(4):758-64. PubMed ID: 15840110
[TBL] [Abstract][Full Text] [Related]
16. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
Langner A; Ashton P; Van De Kerkhof PC; Verjans H
Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis.
Cheng HM; Wu YC; Wang Q; Song M; Wu J; Chen D; Li K; Wadman E; Kao ST; Li TC; Leon F; Hayden K; Brodmerkel C; Chris Huang C
BMC Complement Altern Med; 2017 Sep; 17(1):439. PubMed ID: 28865459
[TBL] [Abstract][Full Text] [Related]
18. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
19. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.
Katayama I; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(6):553-7. PubMed ID: 12459526
[TBL] [Abstract][Full Text] [Related]
20. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA
J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
